Tilaknagar Industries Limited has informed the Exchange regarding Board meeting held on August 11, 2025.
TI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tilaknagar Industries' board approved Q1 FY26 (quarter ended June 30, 2025) results, with consolidated revenue from operations jumping ~30% year-on-year to Rs. 86,387 lakhs (from Rs. 66,486 lakhs). Profit after tax surged ~121% to Rs. 8,851 lakhs (from Rs. 4,009 lakhs), translating to a basic EPS of Rs. 4.57 vs Rs. 2.08. The board also approved a Rs. 25 crore capital expenditure for wholly owned subsidiary Prag Distillery to expand bottling capacity from ~6 lakh to ~36 lakh cases per annum, following a Rs. 33.04 crore LOI fee payment to Andhra Pradesh authorities. M/s. Parikh & Associates was appointed as Secretarial Auditor for five years (FY26-FY30). The filing also highlights a major Rs. 4,150 crore (EUR 413 million) acquisition of Pernod Ricard's Imperial Blue business, subject to CCI approval. Auditors issued a qualified opinion on both standalone and consolidated results, flagging the absence of an impairment assessment of an ENA plant despite impairment indicators.
Strong Q1 performance with over 100% PAT growth and EBITDA margin expansion (from ~7.8% to ~11.4%) signals robust operating momentum, though the qualified auditor opinion on ENA plant impairment is a watch item. The Imperial Blue acquisition (Rs. 4,150 cr) is a transformative deal that will significantly scale the business but introduces execution and leverage risks given the debt-equity funding mix.